Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients

American Journal of Hematology

Volumn 89, Issue 10, 2014, Pages E176-E183

  Nowak, Jacek ^a   Kościńska, Katarzyna ^b   Mika Witkowska, Renata ^a   Rogatko Koroś, Marta ^a   Mizia, Sylwia ^b   Jaskula, Emilia ^c   Polak, Malgorzata ^b   Mordak Domagala, Monika ^b   Lange, Janusz ^b   Gronkowska, Anna ^d   Jedrzejczak, Wieslaw Wiktor ^d   Kyrcz Krzemień, Slawomira ^e   Markiewicz, Miroslaw ^e   Dzierzak Mietla, Monika ^e   Tomaszewska, Agnieszka ^a   Nasilowska Adamska, Barbara ^a   Szczepiński, Andrzej ^a   Halaburda, Kazimierz ^a   Hellmann, Andrzej ^f   Komarnicki, Mieczyslaw ^g   Gil, Lidia ^g   Czyz, Anna ^g   Wachowiak, Jacek ^g   Barańska, Malgorzata ^g   Kowalczyk, Jerzy ^h   Drabko, Katarzyna ^h   Goździk, Jolanta ⁱ   Wysoczańska, Barbara ^c   Bogunia Kubik, Katarzyna ^c   Graczyk Pol, Elzbieta ^a   Witkowska, Agnieszka ^a   Marosz Rudnicka, Anna ^a   Nestorowicz, Klaudia ^a   Dziopa, Joanna ^a   Szlendak, Urszula ^a   Warzocha, Krzysztof ^a   Lange, Andrzej ^b,c   more..

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b Lower Silesian Center for Cellular Transplantation with National Bone Marrow Donor Registry   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f MEDICAL UNIVERSITY OF GDANSK   (Poland)

^g POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^h MEDICAL UNIVERSITY OF LUBLIN   (Poland)

ⁱ JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CHILD; DONOR SELECTION; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; INFANT; MALE; METHODOLOGY; NATURAL KILLER CELL; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; UNRELATED DONORS;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGRAFTS; CHILD; CHILD, PRESCHOOL; DONOR SELECTION; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFANT; KILLER CELLS, NATURAL; MALE; NEOPLASMS; RECEPTORS, KIR; UNRELATED DONORS;

EID: 84907977423     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23802     Document Type: Article

References (32)

1. Pende D, Spaggiari GM, Marcenaro S, et al. Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: Evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 2005;105:2066-2073.
2. Re F, Staudacher C, Zamai L, Vecchio V, Bregni M. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors. Cancer 2006;107:640-648.
3. Stein MN, Shin J, Gudzowaty O, Bernstein AM, Liu JM. Antibody-dependent cell cytotoxicity to breast cancer targets despite inhibitory KIR signaling. Anticancer Res 2006;26:1759-1763.
4. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975;5:117-121.
5. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002;14:615-621.
6. Long EO, Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 2000;12:101-108.
7. Long EO, Barber DF, Burshtyn DN, et al. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev 2001;181:223-233.
8. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005;436:709-713.
9. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:675-678.
10. Lanier LL. Missing self, NK cells, and The White Album. J Immunol 2005;174:6565.
11. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-244.
12. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-2100.
13. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging its predictive value. Blood 2007;110:433-440.
14. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003;102:814-819.
15. Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: Implications for the molecular mechanism. Blood 2009;113:2851-2858.
16. Willemze R, Rodrigues CA, Labopin M, et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia 2009;23:492-500.
17. Pende D, Marcenaro S, Falco M, et al. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 2009;113:3119-3129.
18. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002;100:3825-3827.
19. Brunstein CG, Wagner JE, Weisdorf DJ, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood 2009;113:5628-5634.
20. Thomas LM, Peterson ME, Long EO. Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol 2013;191:3981-3985.
21. Jonsson AH, Yokoyama WM. Assessing licensing of NK cells. Methods Mol Biol 2010;612:39-49.
22. Jonsson AH, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009;101:27-79.
23. Passweg JR, Baldomero H, Gratwohl A, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012;47:906-923.
24. Nowak J, Mika-Witkowska R, Graczyk-Pol E. Genetic Methods of HLA Typing, in Witt M, Dawidowska M and Szczepanski T, (eds.). Molecular Aspects of Hematologic Malignancies. Berlin Heidelberg: Springer-Verlag; 2012, pp 225-239.
25. Robinson J, Halliwell JA, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2013;41:D1222-D1227.
26. Sidney J, Peters B, Frahm N, Brander C, Sette A. HLA class I supertypes: A revised and updated classification. BMC Immunol 2008;9:1-15.
27. Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FT, Witt CS. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: Implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 2008;112:435-443.
28. Nowak J, Mika-Witkowska R, Rogatko-Koros M, et al. Repertoire of MHC-KIR ligands in the Polish population. Tissue Antigens 2010;75:526-526.
29. Nowak J, Mika-Witkowska R, Polak M, et al. Allele and extended haplotype polymorphism of HLA-A, -C, -B, -DRB1 and -DQB1 loci in Polish population and genetic affinities to other populations. Tissue Antigens 2008;71:193-205.
30. Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 2010;207:2065-2072.
31. Elliott JM, Wahle JA, Yokoyama WM. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 2010;207:2073-2079.
32. Bakker AB, Wu J, Phillips JH, Lanier LL. NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals. Hum Immunol 2000;61:18-27.